Review



rabbit anti ythdf3  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 96

    Structured Review

    Proteintech rabbit anti ythdf3
    Rabbit Anti Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 151 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3-specific+Antibody/pm42533115-85-81-85
    Average 96 stars, based on 151 article reviews
    rabbit anti ythdf3 - by Bioz Stars, 2026-11
    96/100 stars

    Images

    Related Articles

    Magnetic Beads:

    Article Title: m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Article Title: m <sup>6</sup> A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Article Title: Methyltransferase-like 3-catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis.
    Article Snippet: 3 Aims: Vascular smooth muscle cells (VSMCs) are involved in the etiology of atherosclerosis, but whether 4 methyltransferase-like 3 (METTL3)-catalyzed N-methyladenosine (mA) modulates the contribution of 5 VSMCs to atherosclerosis remains elusive.. 6 Methods and Results: We generated tamoxifen-inducible VSMC-specific METTL3 knockout mice with 7 VSMC lineage tracing, and found that VSMC-specific METTL3 deficiency substantially attenuated 8 atherosclerosis and reduced the proportion of VSMCs in plaques, due to the inhibition of VSMC 9 atheroprone phenotype as characterized by macrophage-like and inflammatory features as well as high 10 migratory and proliferative capacity. mA-methylated RNA immunoprecipitation sequencing (MeRIP-Seq) 11 combined with polysome profiling analysis mechanistically displayed METTL3 catalyzed mA methylation 12 of myocardin-related transcription factor A (MRTFA) mRNA, and further enhanced YTH N13 methyladenosine RNA binding protein F3 (YTHDF3)-dependent MRTFA mRNA translation.. Conversely, 14 adenovirus or adeno-associated virus-mediated VSMC-specific MRTFA overexpression abolished 15 METTL3 deficiency-mediated alleviation of VSMC atheroprone phenotypic switching and atherosclerotic 16 progression both in vitro and in vivo.

    Incubation:

    Article Title: m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Article Title: m <sup>6</sup> A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Article Title: YTHDF3 promotes the progression of gastric cancer by activating Wnt/β-catenin signaling pathway via targeting NEK7
    Article Snippet: The cells were gently washed three times with PBS once the cell fusion rate had reached 20–30%.The cells were then blocked with 2% bovine serum albumin (BSA-V; Solarbio; Catalog number: A8020), fixed with 4% paraformaldehyde, and penetrated with 0.2% Triton X-10 (Solarbio; Catalog number: T8200). .. YTHDF3 antibody (diluted 1:50; Proteintech; Catalog number: 25537-1-AP) and NEK7 antibody (diluted 1:50; Santa Cruz Biotechnology; Catalog number: sc-393539) were then added to the cells and incubated for an entire night at 4°C. .. The cells were then incubated for one hour at room temperature in a dark setting using fluorescent secondary 309 antibody (diluted 1:500; Cy3 anti-rabbit IgG, FITC anti-mouse IgG; Beyotime Biotechnology Co., Shanghai, China).Lastly, the nuclei were stained with 4’6’-diamino-2-phenylindole dihydrochloride (DAPI; Beyotime Biotechnology Co.).

    Control:

    Article Title: m 6 A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Article Title: m <sup>6</sup> A Modification of Profilin-1 in Vascular Smooth Muscle Cells Drives Phenotype Switching and Neointimal Hyperplasia via Activation of the p-ANXA2/STAT3 Pathway
    Article Snippet: .. Then, protein A/G magnetic beads were incubated with control IgG antibody (30000, Proteintech), METTL3 antibody (15073, Proteintech), or YTHDF3 antibody (25537, Proteintech) at room temperature for 30 minutes. ..

    Lysis:

    Article Title: YTHDF3 promotes the progression of gastric cancer by activating Wnt/β-catenin signaling pathway via targeting NEK7
    Article Snippet: Following the instructions in the PierceTM Classic Magnetic IP/Co-IP Kit (Thermo Scientific, Waltham, USA; Catalog number: 88804), cell lysis was then carried out. .. After lysis, the cell lysate was mixed with 10 μg of the YTHDF3 antibody, 10 μg of the NEK7 antibody, and 10 μg of the IgG antibody from Proteintech. ..

    FLAG-tag:

    Article Title: SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis.
    Article Snippet: .. The following antibodies were used in this study: β-actin antibody (TA-09, Zsbio), β-tubulin antibody (TA-10, Zsbio), SUMO1 antibody (ET1606-53, Huabio), UBC9 antibody (ET1610-21, Huabio), SENP1 antibody (ET7108-53, Huabio), YBX1 antibody (ET1609-10, Huabio), DDX5 antibody (ET1705-32, Huabio), HNRPU antibody (ET7107-10, Huabio), G3BP1 antibody (HA721314, Huabio), ENOA antibody (ET1705-56, Huabio), FLAG-tag antibody (0912-1 or HA601080, Huabio), Myc-tag antibody (EM31105, Huabio), HA-tag antibody (ET1611-49, Huabio), Lamin B1 antibody (ET1606-27, Huabio), His-tag antibody (66005-1-Ig, Proteintech), IGF2BP1 antibody (22803-1-AP, Proteintech), IGF2BP2 antibody (11601-1-AP, Proteintech), IGF2BP3 antibody (14642-1-AP, Proteintech), YTHDF3 antibody (25537-1-AP, Proteintech), p-AKT (ser473) antibody (381555, ZENbioscience), AKT1 antibody (380617, ZEN-bioscience), mouse IgG (A7028, beyotime), rabbit IgG (A7016, beyotime), goat anti-rabbit IgG (HRP) (ZB2301, Zsbio), goat anti-mouse IgG (HRP) (ZB-2305, Zsbio), and anti-mouse Alexa Fluor 488 (Ab150113, Abcam). .. The following reagents were used in this study: ML-792 (HY-114166), N-ethylmaleimide (NEM) (HY-D0843), and cycloheximide (CHX) (HY-12320), were obtained from Med Chem Express.

    Article Title: SENP1-mediated deSUMOylation of YBX1 promotes colorectal cancer development through the SENP1-YBX1-AKT signaling axis
    Article Snippet: .. The following antibodies were used in this study: β-actin antibody (TA-09, Zsbio), β-tubulin antibody (TA-10, Zsbio), SUMO1 antibody (ET1606-53, Huabio), UBC9 antibody (ET1610-21, Huabio), SENP1 antibody (ET7108-53, Huabio), YBX1 antibody (ET1609-10, Huabio), DDX5 antibody (ET1705-32, Huabio), HNRPU antibody (ET7107-10, Huabio), G3BP1 antibody (HA721314, Huabio), ENOA antibody (ET1705-56, Huabio), FLAG-tag antibody (0912-1 or HA601080 , Huabio), Myc-tag antibody (EM31105, Huabio), HA-tag antibody (ET1611-49, Huabio), Lamin B1 antibody (ET1606-27, Huabio), His-tag antibody (66005-1-Ig, Proteintech), IGF2BP1 antibody (22803-1-AP, Proteintech), IGF2BP2 antibody (11601-1-AP, Proteintech), IGF2BP3 antibody (14642-1-AP, Proteintech), YTHDF3 antibody (25537-1-AP, Proteintech), p-AKT (ser473) antibody (381555, ZEN-bioscience), AKT1 antibody (380617, ZEN-bioscience), mouse IgG (A7028, beyotime), rabbit IgG (A7016, beyotime), goat anti-rabbit IgG (HRP) (ZB-2301, Zsbio), goat anti-mouse IgG (HRP) (ZB-2305, Zsbio), and anti-mouse Alexa Fluor 488 ( Ab150113 , Abcam). .. The following reagents were used in this study: ML-792 (HY-114166), N-ethylmaleimide (NEM) (HY-D0843), and cycloheximide (CHX) (HY-12320), were obtained from Med Chem Express.

    Immunoprecipitation:

    Article Title: Methyltransferase-like 3-catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis.
    Article Snippet: 3 Aims: Vascular smooth muscle cells (VSMCs) are involved in the etiology of atherosclerosis, but whether 4 methyltransferase-like 3 (METTL3)-catalyzed N-methyladenosine (mA) modulates the contribution of 5 VSMCs to atherosclerosis remains elusive.. 6 Methods and Results: We generated tamoxifen-inducible VSMC-specific METTL3 knockout mice with 7 VSMC lineage tracing, and found that VSMC-specific METTL3 deficiency substantially attenuated 8 atherosclerosis and reduced the proportion of VSMCs in plaques, due to the inhibition of VSMC 9 atheroprone phenotype as characterized by macrophage-like and inflammatory features as well as high 10 migratory and proliferative capacity. mA-methylated RNA immunoprecipitation sequencing (MeRIP-Seq) 11 combined with polysome profiling analysis mechanistically displayed METTL3 catalyzed mA methylation 12 of myocardin-related transcription factor A (MRTFA) mRNA, and further enhanced YTH N13 methyladenosine RNA binding protein F3 (YTHDF3)-dependent MRTFA mRNA translation.. Conversely, 14 adenovirus or adeno-associated virus-mediated VSMC-specific MRTFA overexpression abolished 15 METTL3 deficiency-mediated alleviation of VSMC atheroprone phenotypic switching and atherosclerotic 16 progression both in vitro and in vivo.



    Similar Products

    96
    Proteintech rabbit anti ythdf3
    Rabbit Anti Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3-specific+Antibody/pm42533115-85-81-85
    Average 96 stars, based on 1 article reviews
    rabbit anti ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    96
    Proteintech ythdf3
    Ythdf3, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3-specific+Antibody/pm41652220-393-18-19
    Average 96 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ythdf3
    Ythdf3, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3+Antibody/pm41862833-75-34-36
    Average 94 stars, based on 1 article reviews
    ythdf3 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    96
    Proteintech ythdf3 antibody
    Ythdf3 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF2+Antibody/pm41803297-239-37-27
    Average 96 stars, based on 1 article reviews
    ythdf3 antibody - by Bioz Stars, 2026-11
    96/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc ythdc2
    Ythdc2, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3+Antibody/bio_rxiv__64898__2026__03__09__710444-135-19-20
    Average 94 stars, based on 1 article reviews
    ythdc2 - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc immunoprecipitation reactions
    a , b Representative images and analysis of INCENP and CDCA8 protein expression levels after YTHDF3 knockdown in PDX-derived organoids (PDXO) by immunofluorescence. Scale bar = 10 μm. Mean protein fluorescence intensity was determined using ImageJ software. c , d Gene plots illustrating YTHDF3 binding to INCENP and CDCA8 mRNAs, as measured by RIP-seq. The normalized read distribution: input (yellow) and YTHDF3 (purple) along the mRNAs. e RNA <t>immunoprecipitation-qPCR</t> (RIP-qPCR) highlighting the indicated mRNA transcripts bound by YTHDF3 in ESCC cells. f , g Representative immunofluorescence staining of newly synthesized proteins and statistical analysis in KYSE30 and KYSE150 cells after YTHDF3 overexpression. Relative fluorescence intensity was determined using ImageJ software. Puromycin staining (green) indicates newly synthesized proteins; nuclei are stained with DAPI (blue). Scale bar = 50 μm. h , i Mock or YTHDF3 knockdown KYSE30 and KYSE150 cells were transfected with pmirGLO-INCENP or pmirGLO-CDCA8 reporters for 48 h. Translation efficiency of INCENP or CDCA8 is defined as the quotient of reporter protein production (F-luc/R-luc). j , k Co-immunoprecipitation of endogenous YTHDF3 and eIF3A in ESCC cells. Representative immunoblots shown in figures were repeated three times independently with similar results. l , m In situ detection and quantification of YTHDF3–eIF3A interactions in the indicated ESCC cell lines were measured using PLA assays, and puncta per cell were determined using ImageJ software. Scale bar = 10 μm, n = 5 biological replicates. n RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in YTHDF3 knockdown KYSE30 cells. o RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in Ebselen-treated KYSE30 cells. RIP-qPCR illustrating the association of YTHDF3 ( p ) and eIF3A ( q ) with the indicated transcripts in METTL3 knockdown KYSE30 cells. Data were analyzed by two-tailed unpaired t-test ( b , e , g , h , i , m ) or one-way ANOVA ( n , o , p , q ). n = 3 biological replicates ( b , e , g , h , i , n , o , p , q ). Data were presented as means ± SD. Source data are provided as a file.
    Immunoprecipitation Reactions, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3+Antibody/pmc12909975-396-14-30
    Average 94 stars, based on 1 article reviews
    immunoprecipitation reactions - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    94
    Cell Signaling Technology Inc anti ythdf3 antibody
    a An experimental design of the present study. Responders (tumor regression grade [TRG] scores of 0–1 or patients who achieved clinical complete or partial response; n = 6) and non-responders (TRG scores of 2–3 or patients who achieved clinical minimal response; n = 8). Created in BioRender. GU, T. (2025) https://BioRender.com/ppcp3bu . b Transcriptomic data from clinical samples (Cohort 1) were subjected to GO enrichment analysis to determine alterations in biological processes, molecular functions, and cellular components. Data are visualized in the provided bubble diagram. c Bubble diagram visualizing the alteration of m 6 A regulators in clinical ESCC sample Cohort 1. d GO enrichment analysis of differentially expressed proteins between shYTHDF3 and Mock cells. The Rich Factor represents the ratio of enriched genes; bubble size denotes gene count, and color indicates -log₁₀P value. Statistical significance was calculated using a two-sided Fisher’s exact test with Benjamini–Hochberg FDR correction. e Rank-based gene set enrichment analysis (GSEA) of signaling pathway alterations and representative protein changes in shYTHDF3 cells. Terms in red represent the primary targets. f Representative immunohistochemical staining images of INCENP, CDCA8, and <t>YTHDF3</t> in ESCC Cohort 1 tissue samples from the indicated responders and non-responders. Scale bar = 250 μm. g INCENP, CDCA8, and YTHDF3 score levels were measured in tissue derived from ESCC Cohort 1 samples. Responders (TRG1, n = 4) and non-responders (TRG 2-3, n = 8). h Correlation between YTHDF3 protein scores and INCENP or CDCA8 protein scores in Cohort 1. Correlation coefficients (R) and P values were determined using a two-sided Pearson correlation test. Shaded areas represent the 95% confidence interval of the regression line. i Representative radiological images and INCENP, CDCA8 IHC-stained tissues (scale bar = 250 μm) in Cohort 2, ESCC patients with favorable and unfavorable responses to NACT [responders (TRG 0–1, n = 31) and non-responders (TRG 2–3, n = 37)]. Red arrows represent the lesion sites. j Immunohistochemical analysis of INCENP and CDCA8 scores in ESCC tissues from Cohort 2, including responders (TRG 1, n = 10) and non-responders (TRG 2-3, n = 37). k Stacked bar plots showing distributions of clinical outcomes (death, n = 10, progression, n = 10, remission, n = 10) in patients with low and high expression of INCENP and CDCA8. Statistical significance was assessed using a two-sided Chi-square test. Data were presented as means ± SD. P -values were determined by a two-tailed unpaired t-test ( g , j ). Source data are provided as a file.
    Anti Ythdf3 Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/ythdf3+antibody/YTHDF3+Antibody/pmc12909975-396-17-30
    Average 94 stars, based on 1 article reviews
    anti ythdf3 antibody - by Bioz Stars, 2026-11
    94/100 stars
      Buy from Supplier

    Image Search Results


    a , b Representative images and analysis of INCENP and CDCA8 protein expression levels after YTHDF3 knockdown in PDX-derived organoids (PDXO) by immunofluorescence. Scale bar = 10 μm. Mean protein fluorescence intensity was determined using ImageJ software. c , d Gene plots illustrating YTHDF3 binding to INCENP and CDCA8 mRNAs, as measured by RIP-seq. The normalized read distribution: input (yellow) and YTHDF3 (purple) along the mRNAs. e RNA immunoprecipitation-qPCR (RIP-qPCR) highlighting the indicated mRNA transcripts bound by YTHDF3 in ESCC cells. f , g Representative immunofluorescence staining of newly synthesized proteins and statistical analysis in KYSE30 and KYSE150 cells after YTHDF3 overexpression. Relative fluorescence intensity was determined using ImageJ software. Puromycin staining (green) indicates newly synthesized proteins; nuclei are stained with DAPI (blue). Scale bar = 50 μm. h , i Mock or YTHDF3 knockdown KYSE30 and KYSE150 cells were transfected with pmirGLO-INCENP or pmirGLO-CDCA8 reporters for 48 h. Translation efficiency of INCENP or CDCA8 is defined as the quotient of reporter protein production (F-luc/R-luc). j , k Co-immunoprecipitation of endogenous YTHDF3 and eIF3A in ESCC cells. Representative immunoblots shown in figures were repeated three times independently with similar results. l , m In situ detection and quantification of YTHDF3–eIF3A interactions in the indicated ESCC cell lines were measured using PLA assays, and puncta per cell were determined using ImageJ software. Scale bar = 10 μm, n = 5 biological replicates. n RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in YTHDF3 knockdown KYSE30 cells. o RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in Ebselen-treated KYSE30 cells. RIP-qPCR illustrating the association of YTHDF3 ( p ) and eIF3A ( q ) with the indicated transcripts in METTL3 knockdown KYSE30 cells. Data were analyzed by two-tailed unpaired t-test ( b , e , g , h , i , m ) or one-way ANOVA ( n , o , p , q ). n = 3 biological replicates ( b , e , g , h , i , n , o , p , q ). Data were presented as means ± SD. Source data are provided as a file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: a , b Representative images and analysis of INCENP and CDCA8 protein expression levels after YTHDF3 knockdown in PDX-derived organoids (PDXO) by immunofluorescence. Scale bar = 10 μm. Mean protein fluorescence intensity was determined using ImageJ software. c , d Gene plots illustrating YTHDF3 binding to INCENP and CDCA8 mRNAs, as measured by RIP-seq. The normalized read distribution: input (yellow) and YTHDF3 (purple) along the mRNAs. e RNA immunoprecipitation-qPCR (RIP-qPCR) highlighting the indicated mRNA transcripts bound by YTHDF3 in ESCC cells. f , g Representative immunofluorescence staining of newly synthesized proteins and statistical analysis in KYSE30 and KYSE150 cells after YTHDF3 overexpression. Relative fluorescence intensity was determined using ImageJ software. Puromycin staining (green) indicates newly synthesized proteins; nuclei are stained with DAPI (blue). Scale bar = 50 μm. h , i Mock or YTHDF3 knockdown KYSE30 and KYSE150 cells were transfected with pmirGLO-INCENP or pmirGLO-CDCA8 reporters for 48 h. Translation efficiency of INCENP or CDCA8 is defined as the quotient of reporter protein production (F-luc/R-luc). j , k Co-immunoprecipitation of endogenous YTHDF3 and eIF3A in ESCC cells. Representative immunoblots shown in figures were repeated three times independently with similar results. l , m In situ detection and quantification of YTHDF3–eIF3A interactions in the indicated ESCC cell lines were measured using PLA assays, and puncta per cell were determined using ImageJ software. Scale bar = 10 μm, n = 5 biological replicates. n RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in YTHDF3 knockdown KYSE30 cells. o RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in Ebselen-treated KYSE30 cells. RIP-qPCR illustrating the association of YTHDF3 ( p ) and eIF3A ( q ) with the indicated transcripts in METTL3 knockdown KYSE30 cells. Data were analyzed by two-tailed unpaired t-test ( b , e , g , h , i , m ) or one-way ANOVA ( n , o , p , q ). n = 3 biological replicates ( b , e , g , h , i , n , o , p , q ). Data were presented as means ± SD. Source data are provided as a file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Expressing, Knockdown, Derivative Assay, Immunofluorescence, Fluorescence, Software, Binding Assay, RNA Immunoprecipitation, Staining, Synthesized, Over Expression, Transfection, Immunoprecipitation, Western Blot, In Situ, Two Tailed Test

    a An experimental design of the present study. Responders (tumor regression grade [TRG] scores of 0–1 or patients who achieved clinical complete or partial response; n = 6) and non-responders (TRG scores of 2–3 or patients who achieved clinical minimal response; n = 8). Created in BioRender. GU, T. (2025) https://BioRender.com/ppcp3bu . b Transcriptomic data from clinical samples (Cohort 1) were subjected to GO enrichment analysis to determine alterations in biological processes, molecular functions, and cellular components. Data are visualized in the provided bubble diagram. c Bubble diagram visualizing the alteration of m 6 A regulators in clinical ESCC sample Cohort 1. d GO enrichment analysis of differentially expressed proteins between shYTHDF3 and Mock cells. The Rich Factor represents the ratio of enriched genes; bubble size denotes gene count, and color indicates -log₁₀P value. Statistical significance was calculated using a two-sided Fisher’s exact test with Benjamini–Hochberg FDR correction. e Rank-based gene set enrichment analysis (GSEA) of signaling pathway alterations and representative protein changes in shYTHDF3 cells. Terms in red represent the primary targets. f Representative immunohistochemical staining images of INCENP, CDCA8, and YTHDF3 in ESCC Cohort 1 tissue samples from the indicated responders and non-responders. Scale bar = 250 μm. g INCENP, CDCA8, and YTHDF3 score levels were measured in tissue derived from ESCC Cohort 1 samples. Responders (TRG1, n = 4) and non-responders (TRG 2-3, n = 8). h Correlation between YTHDF3 protein scores and INCENP or CDCA8 protein scores in Cohort 1. Correlation coefficients (R) and P values were determined using a two-sided Pearson correlation test. Shaded areas represent the 95% confidence interval of the regression line. i Representative radiological images and INCENP, CDCA8 IHC-stained tissues (scale bar = 250 μm) in Cohort 2, ESCC patients with favorable and unfavorable responses to NACT [responders (TRG 0–1, n = 31) and non-responders (TRG 2–3, n = 37)]. Red arrows represent the lesion sites. j Immunohistochemical analysis of INCENP and CDCA8 scores in ESCC tissues from Cohort 2, including responders (TRG 1, n = 10) and non-responders (TRG 2-3, n = 37). k Stacked bar plots showing distributions of clinical outcomes (death, n = 10, progression, n = 10, remission, n = 10) in patients with low and high expression of INCENP and CDCA8. Statistical significance was assessed using a two-sided Chi-square test. Data were presented as means ± SD. P -values were determined by a two-tailed unpaired t-test ( g , j ). Source data are provided as a file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: a An experimental design of the present study. Responders (tumor regression grade [TRG] scores of 0–1 or patients who achieved clinical complete or partial response; n = 6) and non-responders (TRG scores of 2–3 or patients who achieved clinical minimal response; n = 8). Created in BioRender. GU, T. (2025) https://BioRender.com/ppcp3bu . b Transcriptomic data from clinical samples (Cohort 1) were subjected to GO enrichment analysis to determine alterations in biological processes, molecular functions, and cellular components. Data are visualized in the provided bubble diagram. c Bubble diagram visualizing the alteration of m 6 A regulators in clinical ESCC sample Cohort 1. d GO enrichment analysis of differentially expressed proteins between shYTHDF3 and Mock cells. The Rich Factor represents the ratio of enriched genes; bubble size denotes gene count, and color indicates -log₁₀P value. Statistical significance was calculated using a two-sided Fisher’s exact test with Benjamini–Hochberg FDR correction. e Rank-based gene set enrichment analysis (GSEA) of signaling pathway alterations and representative protein changes in shYTHDF3 cells. Terms in red represent the primary targets. f Representative immunohistochemical staining images of INCENP, CDCA8, and YTHDF3 in ESCC Cohort 1 tissue samples from the indicated responders and non-responders. Scale bar = 250 μm. g INCENP, CDCA8, and YTHDF3 score levels were measured in tissue derived from ESCC Cohort 1 samples. Responders (TRG1, n = 4) and non-responders (TRG 2-3, n = 8). h Correlation between YTHDF3 protein scores and INCENP or CDCA8 protein scores in Cohort 1. Correlation coefficients (R) and P values were determined using a two-sided Pearson correlation test. Shaded areas represent the 95% confidence interval of the regression line. i Representative radiological images and INCENP, CDCA8 IHC-stained tissues (scale bar = 250 μm) in Cohort 2, ESCC patients with favorable and unfavorable responses to NACT [responders (TRG 0–1, n = 31) and non-responders (TRG 2–3, n = 37)]. Red arrows represent the lesion sites. j Immunohistochemical analysis of INCENP and CDCA8 scores in ESCC tissues from Cohort 2, including responders (TRG 1, n = 10) and non-responders (TRG 2-3, n = 37). k Stacked bar plots showing distributions of clinical outcomes (death, n = 10, progression, n = 10, remission, n = 10) in patients with low and high expression of INCENP and CDCA8. Statistical significance was assessed using a two-sided Chi-square test. Data were presented as means ± SD. P -values were determined by a two-tailed unpaired t-test ( g , j ). Source data are provided as a file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Immunohistochemical staining, Staining, Derivative Assay, Expressing, Two Tailed Test

    a Cell cycle kinetics were measured by flow cytometry in YTHDF3 knockdown ESCC cells. b Representative confocal images and statistical analysis results of multipolar spindle formation in ESCC cells upon YTHDF3 knockdown. scale bar = 5 μm. IC50 values of ( c ) paclitaxel and d cisplatin after YTHDF3 knockdown in KYSE30 and KYSE150 cells. IC50 values of ( e ) paclitaxel and f cisplatin in KYSE30 and KYSE150 cells with Ebselen treatment. g IC50 values of paclitaxel and cisplatin after overexpression of YTHDF3 in KYSE450 cells. h Plate colony formation assays showing and analyzing overexpression of YTHDF3 in KYSE450 cells treated with paclitaxel and cisplatin. i–n Tumors generated from ESCC cells were subcutaneously xenografted into female NU/NU mice ( i , l ) and divided into the indicated four groups ( n = 6 per group). j , m Effects of each treatment group on tumor growth and k , n tumor weight. Tumor volume = (length × width²)/2 was measured twice per week.IC50 values of paclitaxel ( o ) and cisplatin ( p ) in the shYTHDF3-rescued INCENP or CDCA8 group. Data were analyzed by two-tailed unpaired t-test ( a , b ), one-way ANOVA ( k , n ), and two-way ANOVA ( h , j , m ). n = 3 biological replicates ( a , b , h ). n = 4 biological replicates ( c , d , e , f , g , o , p ). Data were presented as means ± SD. Source data are provided in the file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: a Cell cycle kinetics were measured by flow cytometry in YTHDF3 knockdown ESCC cells. b Representative confocal images and statistical analysis results of multipolar spindle formation in ESCC cells upon YTHDF3 knockdown. scale bar = 5 μm. IC50 values of ( c ) paclitaxel and d cisplatin after YTHDF3 knockdown in KYSE30 and KYSE150 cells. IC50 values of ( e ) paclitaxel and f cisplatin in KYSE30 and KYSE150 cells with Ebselen treatment. g IC50 values of paclitaxel and cisplatin after overexpression of YTHDF3 in KYSE450 cells. h Plate colony formation assays showing and analyzing overexpression of YTHDF3 in KYSE450 cells treated with paclitaxel and cisplatin. i–n Tumors generated from ESCC cells were subcutaneously xenografted into female NU/NU mice ( i , l ) and divided into the indicated four groups ( n = 6 per group). j , m Effects of each treatment group on tumor growth and k , n tumor weight. Tumor volume = (length × width²)/2 was measured twice per week.IC50 values of paclitaxel ( o ) and cisplatin ( p ) in the shYTHDF3-rescued INCENP or CDCA8 group. Data were analyzed by two-tailed unpaired t-test ( a , b ), one-way ANOVA ( k , n ), and two-way ANOVA ( h , j , m ). n = 3 biological replicates ( a , b , h ). n = 4 biological replicates ( c , d , e , f , g , o , p ). Data were presented as means ± SD. Source data are provided in the file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Flow Cytometry, Knockdown, Over Expression, Generated, Two Tailed Test

    INCENP and CDCA8 expression levels were measured in Flag-YTHDF3-WT or Flag-YTHDF3 Mut transfected shYTHDF3#1 (targeting the 3’ UTR of YTHDF3) KYSE30 ( a ) and KYSE150 ( b ) cells. c Cell cycle kinetics were measured in Flag-YTHDF3-WT or Flag-YTHDF3 Mut transfected KYSE150 shYTHDF3#1 cells, n = 3 biological replicates. d Expression of cell cycle proteins in Flag-YTHDF3-WT or Flag-YTHDF3 Mut plasmid-transfected shYTHDF3#1 KYSE150 cells was analyzed by Western blotting. Representative confocal images ( e ) and statistical analysis of metaphase alterations ( f ) in WT or mutant YTHDF3 cells, n = 3 biological replicates, Scale bar = 5 μm. g Western blot analysis showing INCENP and CDCA8 expression levels in shMETTL3 cells. Representative images ( h , j ) and statistical analysis of protein expression levels ( i , k ) after METTL3 knockdown in PDXO cells. n = 3 biological replicates, Scale bar = 10 μm. Relative fluorescence intensity was determined using ImageJ software. Representative confocal images ( l ) and statistical analysis of metaphase alterations ( m ) in shMETTL3 KYSE30 cells, n = 3 biological replicates, Scale bar = 5 μm. n Representative immunohistochemical staining images of METTL3 in Cohort 2 ESCC tissues with the indicated TRG. Scale bar = 250 μm. o Immunohistochemical analysis of METTL3 scores in ESCC tissues from cohort 2, including responders (TRG 1, n = 10) and non-responders (TRG 2-3, n = 37). The box plot shows the median (center line), upper and lower quartiles (box limits), and 1.5 × the interquartile range (whiskers). p Two-sided Pearson correlation was calculated between METTL3 protein scores and INCENP or CDCA8 protein scores in Cohort 2. Shaded areas represent the 95% confidence interval of the regression line. Data were analyzed by two-tailed unpaired t-test ( i , k , m , o ) or one-way ANOVA ( c , f ). Data were presented as means ± SD. Representative immunoblots shown in figures were repeated three times independently with similar results. Source data are provided as a a file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: INCENP and CDCA8 expression levels were measured in Flag-YTHDF3-WT or Flag-YTHDF3 Mut transfected shYTHDF3#1 (targeting the 3’ UTR of YTHDF3) KYSE30 ( a ) and KYSE150 ( b ) cells. c Cell cycle kinetics were measured in Flag-YTHDF3-WT or Flag-YTHDF3 Mut transfected KYSE150 shYTHDF3#1 cells, n = 3 biological replicates. d Expression of cell cycle proteins in Flag-YTHDF3-WT or Flag-YTHDF3 Mut plasmid-transfected shYTHDF3#1 KYSE150 cells was analyzed by Western blotting. Representative confocal images ( e ) and statistical analysis of metaphase alterations ( f ) in WT or mutant YTHDF3 cells, n = 3 biological replicates, Scale bar = 5 μm. g Western blot analysis showing INCENP and CDCA8 expression levels in shMETTL3 cells. Representative images ( h , j ) and statistical analysis of protein expression levels ( i , k ) after METTL3 knockdown in PDXO cells. n = 3 biological replicates, Scale bar = 10 μm. Relative fluorescence intensity was determined using ImageJ software. Representative confocal images ( l ) and statistical analysis of metaphase alterations ( m ) in shMETTL3 KYSE30 cells, n = 3 biological replicates, Scale bar = 5 μm. n Representative immunohistochemical staining images of METTL3 in Cohort 2 ESCC tissues with the indicated TRG. Scale bar = 250 μm. o Immunohistochemical analysis of METTL3 scores in ESCC tissues from cohort 2, including responders (TRG 1, n = 10) and non-responders (TRG 2-3, n = 37). The box plot shows the median (center line), upper and lower quartiles (box limits), and 1.5 × the interquartile range (whiskers). p Two-sided Pearson correlation was calculated between METTL3 protein scores and INCENP or CDCA8 protein scores in Cohort 2. Shaded areas represent the 95% confidence interval of the regression line. Data were analyzed by two-tailed unpaired t-test ( i , k , m , o ) or one-way ANOVA ( c , f ). Data were presented as means ± SD. Representative immunoblots shown in figures were repeated three times independently with similar results. Source data are provided as a a file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Expressing, Transfection, Plasmid Preparation, Western Blot, Mutagenesis, Knockdown, Fluorescence, Software, Immunohistochemical staining, Staining, Two Tailed Test

    a , b Representative images and analysis of INCENP and CDCA8 protein expression levels after YTHDF3 knockdown in PDX-derived organoids (PDXO) by immunofluorescence. Scale bar = 10 μm. Mean protein fluorescence intensity was determined using ImageJ software. c , d Gene plots illustrating YTHDF3 binding to INCENP and CDCA8 mRNAs, as measured by RIP-seq. The normalized read distribution: input (yellow) and YTHDF3 (purple) along the mRNAs. e RNA immunoprecipitation-qPCR (RIP-qPCR) highlighting the indicated mRNA transcripts bound by YTHDF3 in ESCC cells. f , g Representative immunofluorescence staining of newly synthesized proteins and statistical analysis in KYSE30 and KYSE150 cells after YTHDF3 overexpression. Relative fluorescence intensity was determined using ImageJ software. Puromycin staining (green) indicates newly synthesized proteins; nuclei are stained with DAPI (blue). Scale bar = 50 μm. h , i Mock or YTHDF3 knockdown KYSE30 and KYSE150 cells were transfected with pmirGLO-INCENP or pmirGLO-CDCA8 reporters for 48 h. Translation efficiency of INCENP or CDCA8 is defined as the quotient of reporter protein production (F-luc/R-luc). j , k Co-immunoprecipitation of endogenous YTHDF3 and eIF3A in ESCC cells. Representative immunoblots shown in figures were repeated three times independently with similar results. l , m In situ detection and quantification of YTHDF3–eIF3A interactions in the indicated ESCC cell lines were measured using PLA assays, and puncta per cell were determined using ImageJ software. Scale bar = 10 μm, n = 5 biological replicates. n RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in YTHDF3 knockdown KYSE30 cells. o RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in Ebselen-treated KYSE30 cells. RIP-qPCR illustrating the association of YTHDF3 ( p ) and eIF3A ( q ) with the indicated transcripts in METTL3 knockdown KYSE30 cells. Data were analyzed by two-tailed unpaired t-test ( b , e , g , h , i , m ) or one-way ANOVA ( n , o , p , q ). n = 3 biological replicates ( b , e , g , h , i , n , o , p , q ). Data were presented as means ± SD. Source data are provided as a file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: a , b Representative images and analysis of INCENP and CDCA8 protein expression levels after YTHDF3 knockdown in PDX-derived organoids (PDXO) by immunofluorescence. Scale bar = 10 μm. Mean protein fluorescence intensity was determined using ImageJ software. c , d Gene plots illustrating YTHDF3 binding to INCENP and CDCA8 mRNAs, as measured by RIP-seq. The normalized read distribution: input (yellow) and YTHDF3 (purple) along the mRNAs. e RNA immunoprecipitation-qPCR (RIP-qPCR) highlighting the indicated mRNA transcripts bound by YTHDF3 in ESCC cells. f , g Representative immunofluorescence staining of newly synthesized proteins and statistical analysis in KYSE30 and KYSE150 cells after YTHDF3 overexpression. Relative fluorescence intensity was determined using ImageJ software. Puromycin staining (green) indicates newly synthesized proteins; nuclei are stained with DAPI (blue). Scale bar = 50 μm. h , i Mock or YTHDF3 knockdown KYSE30 and KYSE150 cells were transfected with pmirGLO-INCENP or pmirGLO-CDCA8 reporters for 48 h. Translation efficiency of INCENP or CDCA8 is defined as the quotient of reporter protein production (F-luc/R-luc). j , k Co-immunoprecipitation of endogenous YTHDF3 and eIF3A in ESCC cells. Representative immunoblots shown in figures were repeated three times independently with similar results. l , m In situ detection and quantification of YTHDF3–eIF3A interactions in the indicated ESCC cell lines were measured using PLA assays, and puncta per cell were determined using ImageJ software. Scale bar = 10 μm, n = 5 biological replicates. n RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in YTHDF3 knockdown KYSE30 cells. o RIP-qPCR illustrating the association of eIF3A with the indicated transcripts in Ebselen-treated KYSE30 cells. RIP-qPCR illustrating the association of YTHDF3 ( p ) and eIF3A ( q ) with the indicated transcripts in METTL3 knockdown KYSE30 cells. Data were analyzed by two-tailed unpaired t-test ( b , e , g , h , i , m ) or one-way ANOVA ( n , o , p , q ). n = 3 biological replicates ( b , e , g , h , i , n , o , p , q ). Data were presented as means ± SD. Source data are provided as a file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Expressing, Knockdown, Derivative Assay, Immunofluorescence, Fluorescence, Software, Binding Assay, RNA Immunoprecipitation, Staining, Synthesized, Over Expression, Transfection, Immunoprecipitation, Western Blot, In Situ, Two Tailed Test

    a Annotated clinical and molecular characteristics of ESCC patients from Cohort 3 ( n = 65, responder [TRG 0-1, n = 30]; non-responder [TRG 2-3, n = 35]). P -values on the right indicate statistically significant non-random distributions for each attribute. A two-sided Chi-square test was used for categorical variables, and a two-sided unpaired t-test was used for continuous variables. b Representative immunohistochemical staining images of indicated proteins from ESCC, lung cancer, and breast cancer patients of Cohort 3 with favorable and unfavorable NACT treatment responses. scale bar = 250 μm. Immunohistochemical analysis of the indicated proteins in NACT response-classified samples from ( c ) ESCC patients ( n = 65, responder n = 30; non-responder, n = 35]), d lung cancer patients ( n = 26, responder n = 12; non-responder n = 14]), and e breast cancer patients ( n = 22, responder n = 9; non-responder n = 13). f A two-sided Pearson correlation was calculated between the expression of YTHDF3 and INCENP or CDCA8 in biopsy tissues from ESCC patients. Shaded areas represent the 95% confidence interval of the regression line. Kaplan–Meier curves showing progression-free survival (PFS) for patients with ESCC according to high vs. low expression of INCENP ( g ), CDCA8 ( h ), and YTHDF3 ( i ). Statistical significance was assessed using a two-sided log-rank (Mantel–Cox) test; n and p values are shown in the plots. No multiple-comparison correction was applied. Receiver operating characteristic (ROC) curve analyses for predicting the NACT responses in ( j ) ESCC patients, k lung cancer patients, and l breast cancer patients based on the expression levels of YTHDF3, INCENP, and CDCA8. Data were presented as means ± SD. Statistical significance was determined by a two-tailed unpaired t-test ( c , d , e ). Source data are provided as a file.

    Journal: Nature Communications

    Article Title: INCENP and CDCA8 predict neoadjuvant chemotherapy response and outcomes in esophageal squamous cell carcinoma

    doi: 10.1038/s41467-026-68371-x

    Figure Lengend Snippet: a Annotated clinical and molecular characteristics of ESCC patients from Cohort 3 ( n = 65, responder [TRG 0-1, n = 30]; non-responder [TRG 2-3, n = 35]). P -values on the right indicate statistically significant non-random distributions for each attribute. A two-sided Chi-square test was used for categorical variables, and a two-sided unpaired t-test was used for continuous variables. b Representative immunohistochemical staining images of indicated proteins from ESCC, lung cancer, and breast cancer patients of Cohort 3 with favorable and unfavorable NACT treatment responses. scale bar = 250 μm. Immunohistochemical analysis of the indicated proteins in NACT response-classified samples from ( c ) ESCC patients ( n = 65, responder n = 30; non-responder, n = 35]), d lung cancer patients ( n = 26, responder n = 12; non-responder n = 14]), and e breast cancer patients ( n = 22, responder n = 9; non-responder n = 13). f A two-sided Pearson correlation was calculated between the expression of YTHDF3 and INCENP or CDCA8 in biopsy tissues from ESCC patients. Shaded areas represent the 95% confidence interval of the regression line. Kaplan–Meier curves showing progression-free survival (PFS) for patients with ESCC according to high vs. low expression of INCENP ( g ), CDCA8 ( h ), and YTHDF3 ( i ). Statistical significance was assessed using a two-sided log-rank (Mantel–Cox) test; n and p values are shown in the plots. No multiple-comparison correction was applied. Receiver operating characteristic (ROC) curve analyses for predicting the NACT responses in ( j ) ESCC patients, k lung cancer patients, and l breast cancer patients based on the expression levels of YTHDF3, INCENP, and CDCA8. Data were presented as means ± SD. Statistical significance was determined by a two-tailed unpaired t-test ( c , d , e ). Source data are provided as a file.

    Article Snippet: Ten percent (10%) of the lysate was stored as “input”, 80% was used in immunoprecipitation reactions with anti-YTHDF3 antibody (Abcam, ab220161), and the remaining 10% was incubated with rabbit IgG (Cell Signaling Technology) as a negative control and named “IgG”, respectively.

    Techniques: Immunohistochemical staining, Staining, Expressing, Comparison, Two Tailed Test